Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
ARIADPharmaceuticals
3165
ARIADPharmaceuticals
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
ARIAD Pharmaceuticals ($ARIA) is focused on medicines to transform the lives of cancer patients. Read our twitter policy on our site
Suggest edits
Founded
1991
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
Ayala Pharmaceuticals
Korro Bio
HemoGenyx
BioDelivery Sciences International
Ironwood Pharma
UCB
Nevro
Bruker
Xanodyne Pharmaceuticals
DoIt4YourDaughters
Alexa global traffic share
Twitter followers
Overview
Add info
Acquired by
1
09 Jan 2017
Takeda
$5,200,000,000
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
$5,200,000,000
Xconomy
Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio
Health
Strategy
The Motley Fool
Why Ariad Pharmaceuticals, Nevsun Resources, and Ctrip.com International Slumped Today
Stock markets
Earnings
Health
The Motley Fool
Is It Time to Buy Ariad Pharmaceuticals' Stock?
Health
Stock markets
The Motley Fool
3 Charts Show Why Buying Ariad Pharmaceuticals May Be Risky
Earnings
Health
Stock markets
The Motley Fool
Why Ariad Pharmaceuticals Shares Jumped 11.2% In February
Earnings
Health
Stock markets
